The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

A. Nagler

Department of Bone Marrow Transplantation

Hadassah University Hospital

Jerusalem

Israel

[email]@hadassah.org.il

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel. 1998 - 2001
  • The Department of Bone Marrow Transplantation & The Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, The Hebrew University-Hadassah School of Medicine, Jerusalem, Israel. 2000

References

  1. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. Nagler, A., Aker, M., Or, R., Naparstek, E., Varadi, G., Brautbar, C., Slavin, S. Exp. Hematol. (2001) [Pubmed]
  2. Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation. Nagler, A., Or, R., Naparstek, E., Varadi, G., Slavin, S. Exp. Hematol. (2000) [Pubmed]
  3. Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation. Nagler, A., Ackerstein, A., Or, R., Naparstek, E., Slavin, S. Exp. Hematol. (2000) [Pubmed]
  4. The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation. Nagler, A., Morecki, S., Slavin, S. Mol. Biotechnol. (1999) [Pubmed]
  5. Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC). Nagler, A., Condiotti, R., Rabinowitz, R., Schlesinger, M., Nguyen, M., Terstappen, L.W. Med. Oncol. (1999) [Pubmed]
  6. Selective CD4+ T-cell depletion does not prevent graft-versus-host disease. Nagler, A., Condiotti, R., Nabet, C., Naparstek, E., Or, R., Samuel, S., Slavin, S. Transplantation (1998) [Pubmed]
  7. The role of thiotepa in autologous bone marrow transplantation for acute leukemia. Nagler, A., Finlander, R., Or, R., Naparstek, E., Varadi, G., Slavin, S. Leuk. Res. (1998) [Pubmed]
  8. Continuous interleukin-2 infusion combined with cyclophosphamide- based combination chemotherapy in the treatment of hemato-oncological malignancies. Results of a phase I-II study. Nagler, A., Ackerstein, A., Ben-Shahar, M., Or, R., Naparstek, E., Ben-Yosef, R., Slavin, S. Acta Haematol. (1998) [Pubmed]
 
WikiGenes - Universities